Postoperative Residual Curarisation at Arrival in the Post-anesthesia Care Unit
A Non-interventional / Observational Study on Postoperative Residual Curarisation at Arrival in the Post-anesthesia Care Unit After Spontaneous Recovery or After Reversal of the Neuromuscular Block
Sponsor: Merck Sharp & Dohme LLC
Listed as NCT01362647, this observational or N/A phase trial focuses on Postoperative Airway Obstruction and Postoperative Hypoxemia and remains completed. Sponsored by Merck Sharp & Dohme LLC, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2022 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Jun 2022 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Merck Sharp & Dohme LLC
- Onze Lieve Vrouw Hospital
For direct contact, visit the study record on ClinicalTrials.gov .